204 related articles for article (PubMed ID: 24645804)
21. Fc(epsilon)RI and FcgammaRIII/CD16 differentially regulate atopic dermatitis in mice.
Abboud G; Staumont-Sallé D; Kanda A; Roumier T; Deruytter N; Lavogiez C; Fleury S; Rémy P; Papin JP; Capron M; Dombrowicz D
J Immunol; 2009 May; 182(10):6517-26. PubMed ID: 19414806
[TBL] [Abstract][Full Text] [Related]
22. Increased IL-26 Expression Promotes T Helper Type 17- and T Helper Type 2-Associated Cytokine Production by Keratinocytes in Atopic Dermatitis.
Kamijo H; Miyagaki T; Hayashi Y; Akatsuka T; Watanabe-Otobe S; Oka T; Shishido-Takahashi N; Suga H; Sugaya M; Sato S
J Invest Dermatol; 2020 Mar; 140(3):636-644.e2. PubMed ID: 31465744
[TBL] [Abstract][Full Text] [Related]
23. T-helper 1, T-helper 2 and immunosuppressive cytokines in canine atopic dermatitis.
Nuttall TJ; Knight PA; McAleese SM; Lamb JR; Hill PB
Vet Immunol Immunopathol; 2002 Sep; 87(3-4):379-84. PubMed ID: 12072261
[TBL] [Abstract][Full Text] [Related]
24. The role of interleukin-17 in mouse models of atopic dermatitis and contact dermatitis.
Heo WI; Lee KE; Hong JY; Kim MN; Oh MS; Kim YS; Kim KW; Kim KE; Sohn MH
Clin Exp Dermatol; 2015 Aug; 40(6):665-71. PubMed ID: 25684357
[TBL] [Abstract][Full Text] [Related]
25. A novel benzoimidazole derivative, M50367, modulates helper T type I/II responses in atopic dermatitis mice and intradermal melanoma-bearing mice.
Kato Y; Mizuguchi K; Mochizuki H
Biol Pharm Bull; 2005 Jan; 28(1):78-82. PubMed ID: 15635167
[TBL] [Abstract][Full Text] [Related]
26. Etiopathogenesis of atopic dermatitis--an overview.
Pastar Z; Lipozencić J; Ljubojević S
Acta Dermatovenerol Croat; 2005; 13(1):54-62. PubMed ID: 15788148
[TBL] [Abstract][Full Text] [Related]
27. Establishing a Role for Interleukin-17 in Atopic Dermatitis-Related Skin Inflammation.
Tan Q; Yang H; Liu EM; Wang H
J Cutan Med Surg; 2017; 21(4):308-315. PubMed ID: 28279075
[TBL] [Abstract][Full Text] [Related]
28. Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10.
Kaesler S; Volz T; Skabytska Y; Köberle M; Hein U; Chen KM; Guenova E; Wölbing F; Röcken M; Biedermann T
J Allergy Clin Immunol; 2014 Jul; 134(1):92-9. PubMed ID: 24698321
[TBL] [Abstract][Full Text] [Related]
29. Conversion of the CD4+ T cell profile from T(H2)-dominant type to T(H1)-dominant type after varicella-zoster virus infection in atopic dermatitis.
Fujimura T; Yamanashi R; Masuzawa M; Fujita Y; Katsuoka K; Nishiyama S; Mitsuyama M; Nomoto K
J Allergy Clin Immunol; 1997 Aug; 100(2):274-82. PubMed ID: 9275152
[TBL] [Abstract][Full Text] [Related]
30. Effects of anti-allergy drugs on Th1 cell and Th2 cell development mediated by Langerhans cells.
Matsui K; Shi X; Komori S; Higuchi A
J Pharm Pharm Sci; 2020; 23():. PubMed ID: 33120001
[TBL] [Abstract][Full Text] [Related]
31. Topical Application of Doxycycline Inhibits Th2 Cell Development Mediated by Langerhans Cells and Exerts a Therapeutic Effect on Atopic Dermatitis.
Matsui K; Nojima Y; Kajiwara Y; Busujima K; Mori Y
J Pharm Pharm Sci; 2020; 23(1):86-99. PubMed ID: 32338591
[TBL] [Abstract][Full Text] [Related]
32. src homology 2 domain-containing tyrosine phosphatase SHP-1 controls the development of allergic airway inflammation.
Kamata T; Yamashita M; Kimura M; Murata K; Inami M; Shimizu C; Sugaya K; Wang CR; Taniguchi M; Nakayama T
J Clin Invest; 2003 Jan; 111(1):109-19. PubMed ID: 12511594
[TBL] [Abstract][Full Text] [Related]
33. Piperine Ameliorates Trimellitic Anhydride-Induced Atopic Dermatitis-Like Symptoms by Suppressing Th2-Mediated Immune Responses via Inhibition of STAT6 Phosphorylation.
Choi DW; Jung SY; Shon DH; Shin HS
Molecules; 2020 May; 25(9):. PubMed ID: 32392825
[TBL] [Abstract][Full Text] [Related]
34. IL-17A as an inducer for Th2 immune responses in murine atopic dermatitis models.
Nakajima S; Kitoh A; Egawa G; Natsuaki Y; Nakamizo S; Moniaga CS; Otsuka A; Honda T; Hanakawa S; Amano W; Iwakura Y; Nakae S; Kubo M; Miyachi Y; Kabashima K
J Invest Dermatol; 2014 Aug; 134(8):2122-2130. PubMed ID: 24480880
[TBL] [Abstract][Full Text] [Related]
35. Regulation of immunological balance by sustained interferon-γ gene transfer for acute phase of atopic dermatitis in mice.
Watcharanurak K; Nishikawa M; Takahashi Y; Kabashima K; Takahashi R; Takakura Y
Gene Ther; 2013 May; 20(5):538-44. PubMed ID: 22914497
[TBL] [Abstract][Full Text] [Related]
36. Local but not systemic administration of IFN-gamma during the sensitization phase of protein antigen immunization suppress Th2 development in a murine model of atopic dermatitis.
Wang LF; Wu JT; Sun CC
Cytokine; 2002 Aug; 19(3):147-52. PubMed ID: 12242081
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of IFN-alpha on the expression of various TH2 cytokines in human CD4+ T cells.
Shibuya H; Hirohata S
J Allergy Clin Immunol; 2005 Jul; 116(1):205-12. PubMed ID: 15990796
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of Th2 differentiation and GATA-3 expression by BCL-6.
Kusam S; Toney LM; Sato H; Dent AL
J Immunol; 2003 Mar; 170(5):2435-41. PubMed ID: 12594267
[TBL] [Abstract][Full Text] [Related]
39. Production and pharmacologic modulation of the granulocyte-associated allergic responses to ovalbumin in murine skin models induced by injecting ovalbumin-specific Th1 or Th2 cells.
Terui T; Sano K; Okada M; Shirota H; Honda M; Ozawa M; Hirasawa N; Tamura G; Tagami H
J Invest Dermatol; 2001 Aug; 117(2):236-43. PubMed ID: 11511299
[TBL] [Abstract][Full Text] [Related]
40. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
Tao X; Constant S; Jorritsma P; Bottomly K
J Immunol; 1997 Dec; 159(12):5956-63. PubMed ID: 9550393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
